Coronavirus
Smiths Detection Collaborates with Attomarker to Develop Triple Antibody Testing Device for COVID-19
The Medicines and Healthcare Products Regulatory Agency approved Attomarker’s Triple Antibody Test for use by the National Health Service (NHS) in the U.K. as of July 8. Keep Reading